Just when you thought that the industry that made money on bisphenol A could not have been any cozier with the federal agency regulating the chemical comes another revelation.

Cozy? How about joined at the hip?

An article published Sunday in the Journal Sentinel revealed disturbing e-mails between the U.S. Food and Drug Administration and chemical industry lobbyists. The gist: the FDA relying on lobbyists to evaluate the chemical's risks, track legislation to ban it and monitor ...

( Back to Article )